FDA UNTITLED_LETTER - LEESAR, INC - April 29, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore LEESAR, INC

Record Details

This UNTITLED LETTER record concerns LEESAR, INC, with an inspection on April 29, 2025, issued by the Office of Compounding Quality and Compliance, covering drugs.

Company: LEESAR, INC
Inspection Date: April 29, 2025
Product Type: Drugs
Office: Office of Compounding Quality and Compliance
Person: F. Gail Bormel (F.)

Open in Dashboard

ID · 44b860c3-98cb-44d4-82a5-a3df576d2475

Violation Codes10

21 U.S.C. 353b21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 CFR 211(c)(2)21 U.S.C. 355(a)21 CFR 211(a)21 CFR 201.11521 CFR 211.22(d)21 U.S.C. 352(f)(1)21 U.S.C. 331(k)

Full citation text and observation details available on the Dashboard.